BTS MDR-TB Clinical Advice Service
The MDR-TB Clinical Advice Service provides advice and support to clinicians across the UK who encounter multidrug-resistant tuberculosis (MDR-TB). The advice is offered by a multidisciplinary panel of Clinical Service Advisers, with expertise in areas such as respiratory medicine, infectious diseases, microbiology, pharmacy and public health. The advice is provided via a secure online case discussion forum and at monthly MDT meetings which are held via Teams. If you are a NHS professional and would like to observe the case discussions at an MDT, please mdrtb@brit-thoracic.org.uk.
If you are a clinician who would like to make use of this service for advice, please register for an account:
BTS MDR-TB Clinical Advice Service
Please find a Quick Start Guide for clinicians and other useful resources:
Quick Start Guide to the CAS for clinicians
MDR-TB CAS Sheet A - Patient Demographics
MDR-TB CAS Sheet B - Clinical Information
MDR-TB CAS Sheet C - Follow up
For more information on the data being collected and patient consent forms, please see below:
Fair Processing Information & Welsh Language version
MDR-TB Patient Information Consent Form & Welsh Language version
MDR-TB Parent / Guardian Information Consent Form & Welsh Language version
MDR-TB Patients Unable to Consent Information Form & Welsh Language version
Educational Resources and Webinars
MDR-TB Clinical Simulated Case Discussion 2025
Date: Tuesday 21 October 2025
Following the success of the first MDR-TB Clinical Advice Service webinar (2024) we repeated the offer, in October 2025, with new case content. The free webinar presented a simulation of one of the virtual MDTs that run each month as part of the BTS MDR-TB Clinical Advice Service.
Three fictional cases, two adult and one paediatric, were discussed, and topics covered included:
- MDR-TB treatment principles and drug toxicity management
- MDR-TB new regimens for treatment
- MDR-TB with End Stage Renal Failure (ESRF)
- MDR-TB in children
- MDR-TB Public Health concerns
- Other complex TB
Watch a recording of this webinar here: MDR-TB Clinical Simulated Case Discussion 2025
You may wish to review current WHO guidelines on tuberculosis treatment and care on the and a link to the World Health Organisation website.
For further information or queries, please mdrtb@brit-thoracic.org.uk
Downloads
- BTS MDR-TB Clinical Advice Service Annual Report 2024
- Webinar: MDR-TB CAS Simulated MDT case discussion - held on 21/05/2024
- BTS MDR-TB Clinical Advice Service Annual Report 2023
- Addendum to BTS MDR-TB Clinical Advice Service Annual Report 2023 (March 2024)
- BTS MDR-TB Clinical Advice Service Annual Report 2021
- BTS MDR-TB Clinical Advice Service: Drug Toxicity in the UK - Supplemental Report 2021
- BTS MDR-TB Clinical Advice Service Annual Report 2020
- BTS MDR-TB Clinical Advice Service Annual Report - summary 2020
- BTS WInter Meeting 2019 - presentation on the MDR-TB Clinical Advice Service
Links
- NHSBSA - DHSC - Endorsement for TB Treatment (VO.2) - Nov 2025
- WHO rapid communication key updates to treatment of drug-resistant tuberculosis - June 2024
- NHS England BPaLM-Clinical Commissioning Statement. 26.06.2024
- WHO consolidated guidelines on drug-resistant tuberculosis treatment - December 2022
- TB Alert
- BTS MDR-TB Clinical Statement - November 2016